Search

everythinglearnresearchcommunity

for

Search:↓

New compounds show promise for treating hair loss, enlarged prostate, and prostate cancer, with some being more effective and having different side effects than current treatments.

New research is needed to create better drugs that block the enzyme responsible for conditions like male baldness and prostate enlargement.

Researchers developed a model to predict how well certain compounds can block an enzyme related to hair loss and prostate issues, suggesting a 50 mg dose of finasteride might be effective based on lab and body data.

Finasteride's effect on hair loss and prostate enlargement depends on its binding to an enzyme, with maximum impact at 0.2 mg dose.

A new compound effectively inhibits human 5α-reductase 1.

Topical finasteride doesn't reduce DHT levels, hinting at an endocrine role in hair loss.

Natural herbal compounds might treat certain medical conditions by reducing DHT levels, but more research is needed to confirm their effectiveness and safety.

New treatments for prostate cancer and BPH show promise, including novel compounds that target hormone synthesis and response.

Finasteride lowers DHT levels and raises testosterone in a dose-dependent way.

Post-finasteride syndrome's existence is uncertain; more research needed.

Male pattern baldness might have evolved to help protect against prostate cancer by increasing UV radiation on the scalp.

Common latent viruses might contribute to male-pattern baldness by disrupting cell processes that normally suppress hair loss-related proteins.

New methods for measuring dutasteride are effective and reliable.

The models can help find better inhibitors for conditions like baldness and prostate disorders.

Ganoderma lucidum may help treat enlarged prostate in rats.

Low doses of mixed chemicals cause permanent reproductive malformations in male rats.

Topical finasteride helps regrow hair and reduce balding without side effects.

Male hormones worsen kidney transplant damage, but blocking them helps.

Androgens increase EPO production, finasteride doesn't significantly impact it.

Platelets play a key role in the immune system and their lifespan and aging are important for developing new treatments.

Modified liposomes with exosomes effectively deliver RNA to stem cells.

Some skin medications can harm male fertility, but they don't seem to cause birth defects from father's exposure.

The document concludes that hormonal biomarkers are key for diagnosing hyperandrogenemia in women and hypogonadism in men.

Urologic diseases and treatments in older men can negatively affect fertility, and doctors should talk to patients about this.

Over 50% of women over 50 experience hair loss, with minoxidil being the only proven effective treatment.

Silver nanoparticles from Mitracarpus scaber protect the liver and reduce prostate enlargement.

More research is needed to confirm safflower's traditional medicinal uses.

Men generally have more severe COVID-19 cases and higher death rates than women due to biological differences.

Flutamide rarely causes liver toxicity in prostate cancer patients.

Men, especially older ones with health issues like prostate cancer, may have worse COVID-19 outcomes and could benefit from therapies targeting male hormones.